Last edition
News about
Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research
Simcere Pharmaceutical has entered a research collaboration with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis (IPF).
Domino India Celebrates 30 Years of Excellence
Domino India marked 30 years of operations with a landmark employee summit in Jaipur, bringing together more than 350 employees from across the country. The 5-day celebration highlighted the company’s growth, achievements, and commitment to innovation, collaboration, and employee excellence.
Lilly's Jaypirca Cuts Disease Progression Risk by 45 Percent in CLL/SLL
Lilly’s Jaypirca (pirtobrutinib) reduced the risk of disease progression or death by 45 percent when combined with a time-limited venetoclax regimen in previously treated CLL/SLL patients, according to phase 3 BRUIN CLL-322 trial results.
US FDA Approves KEYTRUDA-WELIREG Combination for Adjuvant ccRCC
The US Food and Drug Administration (FDA) has approved KEYTRUDA and KEYTRUDA QLEX in combination with WELIREG for the adjuvant treatment of certain patients with clear cell Renal Cell Carcinoma (ccRCC). The approval expands treatment options for kidney cancer patients at high risk of recurrence following surgery.
Waters Launches Coin Cell DSC for Advanced Battery Safety Testing
Waters has launched the Coin Cell DSC, an advanced analytical instrument that combines thermal, evolved gas, and electrochemical analysis to enhance battery safety testing and energy storage research.
US FDA Approves Bayer's AMBELVIST for Contrast-Enhanced MRI
Bayer’s AMBELVIST (gadoquatrane) has received US FDA approval for contrast-enhanced MRI to detect and visualise lesions with abnormal vascularity in the Central Nervous System (CNS) and other body regions. The approval expands advanced imaging options with a next-generation gadolinium-based contrast agent for improved diagnostic evaluation.
Dr. Jitendra Singh Urges Stronger Industry-Academia Partnerships to Accelerate Science-led Growth
Union Minister Dr. Jitendra Singh called for stronger industry-academia partnerships to drive science-led growth, reaffirming the government’s commitment to easing research and innovation. He also highlighted the CSIR Technology Showcase Portal, featuring over 800 industry-ready technologies to accelerate commercialisation and technology adoption.
US Approves TRUQAP for PTEN-Deficient Metastatic Prostate Cancer
TRUQAP (capivasertib) has been approved in the US as the first targeted treatment for PTEN-deficient metastatic Hormone-Sensitive Prostate Cancer (mHSPC). The approval is supported by phase 3 CAPItello-281 data showing a 19 percent reduction in the risk of disease progression or death.
Dr. Reddy's Announces the First-to-Market Launch of Bosutinib Tablets 400 mg
Dr. Reddy’s has launched Bosutinib Tablets 400 mg in the US, becoming the first generic equivalent of Bosulif available in the market.
Concord Biotech Successfully Completes ANVISA Inspection at Limbasi API Manufacturing Facility
Concord Biotech has successfully completed an ANVISA inspection at its Limbasi Active Pharmaceutical Ingredient (API) manufacturing facility, strengthening its regulatory standing and expansion into Brazil's pharmaceutical market.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy